The market is entering its historically strong seasonal period, which runs from late October until about mid-May. If this holds true again this/next year, the Indexes will be pounding out new all-time highs on a regular basis. While this could happen, we must also be on the lookout for the “promised” pull-back. [more]

New 25-page Update Equity Research Report on XORTX, with a Buy rating and one-year price target of $26.00/share. The Company has two potential late-stage drugs in development focused on kidney diseases with one drug that could be approved within the next 18 months and the other drug that could have an orphan drug indication on the market in 2025. [more]

October proved to be a good month for our Portfolio, and now we are heading into the market’s strongest period. Our excellent dividend-paying companies and the strong overall market performance combined to send our Portfolio up 8.2% since its inception last June 1. [more]

Canadian Utilities has an attractive dividend yield and also some appreciation potential from current levels. [more]

In this short video, Tracy Weslosky of InvestorIntel interviews Chris Thompson of eResearch about eResearch’s Update Report on EQ Works pertaining to the Company’s recent release of its Q2/2021 financial results that had revenue increases 71% Q/Q and 74% Y/Y. [more]

This is an update article to the original “Chart of the Day” report on Suncor from September 20, 2021. Suncor’s stock price is up 19% in 3 weeks. [more]

The market is about to enter its traditional seasonal period of strength. This extends from about the middle of October until the end of May. Meanwhile, October can be very volatile so continued caution is required. [more]

We cautioned last month that September is typically a difficult month for the stock market. This year has been no different. Our Portfolio dropped 2.0%, while the S&P TSX Composite Index fared slightly worse, dropping 2.5%. The S&P 500 Index was down 4.8%, while the DJIA was off 4.3%. [more]